Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus

Autor: VI Bouloukos, AN Pehlivanidis, Triandafillos P. Didangelos, Athanasios A. Papageorgiou, Dimitrios P. Mikhailidis, Vasilios G. Athyros, Athanasios N. Symeonidis

Publikováno v: Angiology. 54:679-690

This is a prospective evaluation of the effect of structured care of dyslipidemia with atorvas tatin (strict implementation of guidelines) versus usual care (physician's standard of care) on morbidity and mortality of patients with coronary heart dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9b7e52c26f21edbae78ae3517d79defe
https://doi.org/10.1177/000331970305400607

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

Autor: Anna I. Kakafika, Anatoly Langer, Stella S. Daskalopoulou, VI Bouloukos, Athanasios N. Symeonidis, Vasilios G. Athyros, Dimitri P. Mikhailidis, AN Pehlivanidis, Athanasios A. Papageorgiou

Publikováno v: Current medical research and opinion. 20(9)

Although available guidelines suggest reducing low-density lipoprotein cholesterol (LDL-C) to below 100 mg/dL (2.6 mmol/L), the importance of target-oriented therapy remains controversial. To assess whether achieving guideline-based targets is of ben

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e2038711a45740cea2e4a43c9d04693
https://pubmed.ncbi.nlm.nih.gov/15383187

Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

Autor: Moses Elisaf, VI Bouloukos, AN Pehlivanidis, Athanasios A. Papageorgiou, Dimitri P. Mikhailidis, Athanasios N. Symeonidis, Bodosakis R. Mercouris, Vasilios G. Athyros

Publikováno v: Current medical research and opinion. 20(5)

To investigate the relationship between changes in high density lipoprotein cholesterol(HDL-C) levels after statin treatment and the risk for coronary heart disease (CHD)-related events in the secondary CHD prevention GREek Atorvastatin and Coronary

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed69bfb55eae20b2cd39d4df1618b08
https://pubmed.ncbi.nlm.nih.gov/15171226

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study

Autor: M.S. Elisaf, Athanasios N. Symeonidis, AN Pehlivanidis, Vasilios G. Athyros, Athanasios A. Papageorgiou, VI Bouloukos, D. P. Mikhailidis

It has been reported recently that of 4483 apparently healthy men participating in the physicians’ health study with an initial serum creatinine (SCr) < 115 µmol/litre (13 mg/litre), those with low high density lipoprotein (HDL) cholesterol and hi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c77e928f10f0a48a0f596bb32e8fe4aa
http://olympias.lib.uoi.gr/jspui/handle/123456789/24542

Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study.

Autor: Athyros VG; Atherosclerosis Unit, Aristotelian University, Hippocration Hospital, 49 Konstantinoupoleos St, Thessaloniki, 546 42, Greece. athyros@med.auth.gr, Mikhailidis DP, Papageorgiou AA, Bouloukos VI, Pehlivanidis AN, Symeonidis AN, Kakafika AI, Daskalopoulou SS, Elisaf M

Publikováno v: Platelets [Platelets] 2005 Mar; Vol. 16 (2), pp. 65-71.